We are live on
!
Find out more
TAM
Todd Asset Management Portfolio holdings
AUM
$5.11B
1-Year Est. Return
34.73%
This Fund
S&P 500
This Quarter
Est. Return
+21.37%
1 Year Est. Return
+34.73%
3 Year Est. Return
+91.09%
5 Year Est. Return
+118.42%
10 Year Est. Return
+378.46%
AUM
$3.16B
AUM Growth
+$541M
(+21%)
Cap. Flow
-$32.5M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
231
New
34
Increased
51
Reduced
103
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$30.7M |
| 2 |
DaVita
DVA
|
+$23.5M |
| 3 |
Lockheed Martin
LMT
|
+$23.3M |
| 4 |
Open Text
OTEX
|
+$21.3M |
| 5 |
Fresenius Medical Care
FMS
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$21.3M |
| 2 |
Eli Lilly
LLY
|
+$18.2M |
| 3 |
F5
FFIV
|
+$18.1M |
| 4 |
United Rentals
URI
|
+$17.8M |
| 5 |
Biogen
BIIB
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.81% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Healthcare | 11.42% |
| 5 | Industrials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PC
176
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| $101K | ﹤0.01% |
+11,643
| New | +$101K |
|
177
Aegon
AEG
$14B
| – | – |
-441,894
| Closed | -$1.01M |
|
|
178
Biogen
BIIB
$30B
| – | – |
-47,731
| Closed | -$15.1M |
|
179
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.78B
| – | – |
-2,088
| Closed | -$41K |
|
180
Delta Air Lines
DAL
$57.5B
| – | – |
-385,152
| Closed | -$11M |
|
181
D.R. Horton
DHI
$40B
| – | – |
-322,867
| Closed | -$11M |
|
182
Fastenal
FAST
$54.7B
| – | – |
-917,516
| Closed | -$14.3M |
|
183
Hewlett Packard
HPE
$63.4B
| – | – |
-1,062,344
| Closed | -$10.3M |
|
184
HSBC
HSBC
$365B
| – | – |
-36,810
| Closed | -$1.03M |
|
185
JD.com
JD
$44.6B
| – | – |
-77,100
| Closed | -$3.12M |
|
186
Kohl's
KSS
$2.17B
| – | – |
-35,506
| Closed | -$518K |
|
|
187
Eli Lilly
LLY
$1.02T
| – | – |
-130,845
| Closed | -$18.2M |
|
188
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
| – | – |
-18,795
| Closed | -$486K |
|
189
Synchrony
SYF
$24.7B
| – | – |
-471,578
| Closed | -$7.59M |
|
190
Xerox
XRX
$387M
| – | – |
-463,268
| Closed | -$8.77M |
|
|
CERN
191
DELISTED
Cerner Corp
CERN
| – | – |
-232,242
| Closed | -$14.6M |
|
|
AGN
192
DELISTED
Allergan plc
AGN
| – | – |
-120,195
| Closed | -$21.3M |
|
|
KNBWY
193
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
| – | – |
-139,900
| Closed | -$2.73M |
|
|
DCM
194
DELISTED
NTT DOCOMO, Inc.
DCM
| – | – |
-10,088
| Closed | -$314K |
|
Similar funds
CIA
AC
BG
EIC
PA
CS
NC
VT
Todd Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Todd Asset Management held 231 positions worth $3.16B, up 21% from $2.62B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Todd Asset Management's Q2 2020 filing shows 34 new, 51 increased, 103 reduced and 25 closed positions. Its largest new stake was Bristol-Myers Squibb: 513,403 shares worth $30.2M. The largest sale was Allergan plc, an estimated $21.3M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- Todd Asset Management's largest Q2 2020 buy was Bristol-Myers Squibb: 513,403 shares worth $30.2M.
- Todd Asset Management added most to Humana in Q2 2020, an estimated $13.4M increase.
- Todd Asset Management's biggest Q2 2020 reduction was F5, cutting an estimated $18.1M.
- Todd Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $21.3M.
- Todd Asset Management's ten largest holdings make up 15% of its $3.16B portfolio in Q2 2020.
- Todd Asset Management opened 34 new positions and closed 25 in Q2 2020.
- Todd Asset Management's portfolio value rose 21% quarter-over-quarter to $3.16B.
Based on Todd Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.